These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15019164)

  • 61. Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
    Muraoka A; Tokiwa T; Sato J
    Br J Cancer; 1989 Apr; 59(4):569-72. PubMed ID: 2469455
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma. An in situ hybridization and immunohistochemical study.
    Fiorentino M; Grigioni WF; Baccarini P; D'Errico A; De Mitri MS; Pisi E; Mancini AM
    Diagn Mol Pathol; 1994 Mar; 3(1):59-65. PubMed ID: 8162257
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Molecular mechanisms of progression in human hepatocarcinogenesis].
    Breuhahn K
    Pathologe; 2010 Oct; 31 Suppl 2():170-6. PubMed ID: 20711584
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression.
    Yao N; Yao D; Wang L; Dong Z; Wu W; Qiu L; Yan X; Yu D; Chen J; Sai W; Zhang H; Yang J
    Tumour Biol; 2012 Oct; 33(5):1767-76. PubMed ID: 22684773
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells.
    Yang D; Faris R; Hixson D; Affigne S; Rogler CE
    J Virol; 1996 Sep; 70(9):6260-8. PubMed ID: 8709253
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The interaction between 5-fluorouracil and marini on QGY cell line in vitro].
    He S; Cheb S; Tang W; Zuo G; Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):160. PubMed ID: 12108392
    [No Abstract]   [Full Text] [Related]  

  • 67. Expression of insulin-like growth factor II mRNA in hepatocellular carcinoma.
    Ng IO; Lee JM; Srivastava G; Ng M
    J Gastroenterol Hepatol; 1998 Feb; 13(2):152-7. PubMed ID: 10221816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells.
    Ramachandran C; Khatib Z; Petkarou A; Fort J; Fonseca HB; Melnick SJ; Escalon E
    J Neurooncol; 2004; 67(1-2):19-28. PubMed ID: 15072444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.
    Wang Z; Ruan YB; Guan Y; Liu SH
    World J Gastroenterol; 2003 Feb; 9(2):267-70. PubMed ID: 12532445
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Integrin-mediated control of cell growth.
    Schuppan D; Ocker M
    Hepatology; 2003 Aug; 38(2):289-91. PubMed ID: 12883471
    [No Abstract]   [Full Text] [Related]  

  • 71. Use of the IGF-I antisense strategy in the treatment of the hepatocarcinoma.
    Upegui-Gonzalez LC; Duc HT; Buisson Y; Arborio M; Lafarge-Frayssinet C; Jasmin C; Guo Y; Trojan J
    Adv Exp Med Biol; 1998; 451():35-42. PubMed ID: 10026847
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of human procathepsin D on proliferation of human cell lines.
    Vĕtvicka V; Vĕktvicková J; Fusek M
    Cancer Lett; 1994 May; 79(2):131-5. PubMed ID: 8019970
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [IGF II expressing malignant giant solitary fibrous tumour of the liver].
    Arredondo Chaves J; Labiano Miravalles T; Pardo Sánchez F; Sola Gallego JJ
    Cir Esp; 2012 Feb; 90(2):122-5. PubMed ID: 21277570
    [No Abstract]   [Full Text] [Related]  

  • 74. Different effects of p58PITSLRE on the apoptosis induced by etoposide, cycloheximide and serum-withdrawal in human hepatocarcinoma cells.
    Cai MM; Zhang SW; Zhang S; Chen S; Yan J; Zhu XY; Hu Y; Chen C; Gu JX
    Mol Cell Biochem; 2002 Sep; 238(1-2):49-55. PubMed ID: 12349909
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [An anticancer fluorescent substance in the human urine. II. Biological properties of an anticancer fluorescent substance].
    Chen YQ
    Zhonghua Zhong Liu Za Zhi; 1983 Jul; 5(4):266-9. PubMed ID: 6653342
    [No Abstract]   [Full Text] [Related]  

  • 76. Growth inhibition of a human tumor cell strain by 5-fluoro-2-deoxyuridine: time parameters for subsequent reversal by thymidine.
    EIDINOFF ML; RICH MA
    Cancer Res; 1959 Jun; 19(5):521-4. PubMed ID: 13663041
    [No Abstract]   [Full Text] [Related]  

  • 77. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma.
    Dimri M; Satyanarayana A
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32093152
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis.
    Vacante F; Senesi P; Montesano A; Paini S; Luzi L; Terruzzi I
    Int J Endocrinol; 2019; 2019():7570146. PubMed ID: 30774659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3.
    Greenall SA; Donoghue J; Johns TG; Adams TE
    Transl Oncol; 2018 Aug; 11(4):971-978. PubMed ID: 29933129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.
    Tang S; Chen Y; Feng S; Yi T; Liu X; Li Q; Liu Z; Zhu C; Hu J; Yu X; Wang M; Cao G; Tang H; Bie C; Ma F; Tang H; Du G; Huang J
    Oncotarget; 2017 Nov; 8(59):99871-99888. PubMed ID: 29245946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.